IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SACCHETTI, Emilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.775
EU - Europa 4.311
AS - Asia 2.072
OC - Oceania 24
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 8
Totale 16.224
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.735
CN - Cina 1.420
UA - Ucraina 1.203
IT - Italia 1.112
DE - Germania 523
PL - Polonia 376
GB - Regno Unito 298
HK - Hong Kong 261
FI - Finlandia 245
IE - Irlanda 195
SG - Singapore 183
IN - India 136
FR - Francia 127
RU - Federazione Russa 53
SE - Svezia 49
BE - Belgio 41
CA - Canada 38
CZ - Repubblica Ceca 35
NL - Olanda 26
TR - Turchia 20
AU - Australia 17
IR - Iran 16
VN - Vietnam 16
EU - Europa 12
MU - Mauritius 10
CH - Svizzera 8
GR - Grecia 7
NZ - Nuova Zelanda 7
ZA - Sudafrica 6
ID - Indonesia 5
MA - Marocco 5
ES - Italia 4
SA - Arabia Saudita 4
AR - Argentina 3
JP - Giappone 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
MX - Messico 2
RO - Romania 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 16.224
Salva come PNG Salva come JPEG
Città #
Fairfield 1.346
Woodbridge 1.195
Jacksonville 893
Houston 810
Ashburn 702
Ann Arbor 604
Chandler 597
Seattle 526
Cambridge 514
Wilmington 483
Warsaw 375
Princeton 360
Nanjing 316
Hong Kong 258
New York 256
Dublin 191
Beijing 170
Brescia 160
Helsinki 128
Nanchang 120
Singapore 108
Lancaster 101
Milan 101
Shenyang 98
Dearborn 94
Hebei 89
Des Moines 86
Changsha 83
Jinan 82
Tianjin 70
Jiaxing 52
San Diego 50
Shanghai 48
Boardman 46
Ningbo 38
Hangzhou 35
Washington 34
San Mateo 33
Inzago 32
Zhengzhou 32
Lanzhou 30
Los Angeles 29
Norwalk 27
Brussels 26
Brno 25
Leawood 24
Taizhou 24
Kunming 23
London 23
San Francisco 22
Verona 21
Haikou 20
Mantova 18
Augusta 17
Brugherio 17
Toronto 17
Rome 15
Taiyuan 15
Bareggio 14
Berchem 14
Candia 14
Dong Ket 14
Olgiate Olona 14
Fuzhou 13
Guangzhou 13
Orange 13
Seregno 13
Kocaeli 12
Pavia 12
Changchun 11
Coventry 11
Monmouth Junction 11
Mozzate 11
Napoli 11
Ardabil 9
Munich 9
Olomouc 9
Redwood City 9
Vancouver 9
Nova Milanese 8
Varese 8
Albiate 7
Camporosso 7
Cologno Monzese 7
Hefei 7
Lentate Sul Seveso 7
Paderno Dugnano 7
Torino 7
Athens 6
Bela-Bela 6
Castellanza 6
Cormano 6
Dallas 6
Kilburn 6
Lodi 6
Melbourne 6
Moscow 6
Nürnberg 6
Auckland 5
Mede 5
Totale 12.090
Salva come PNG Salva come JPEG
Nome #
Analysis of DTI brain data and implementation in a novel software (DTILAB) 841
New Copy Number Variations in Schizophrenia 260
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 257
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 210
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 176
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 174
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 167
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 145
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 141
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 139
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 136
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: The QUERISOLA trial. 135
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 130
Schizotassia 129
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 129
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 127
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 125
Cognitive remediation in schizophrenia. 125
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 124
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 123
A STUDY OF EFFECTIVENESS OF STRUCTURED GROUP PSYCHOEDUCATION FOR BIPOLAR PATIENTS. A CONTROLLED TRIAL IN ITALY 120
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 120
Adherence to antipsychotics in schizophrenia. 117
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 114
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 113
Comparison of quetiapine (‘Seroquel’), olanzapine and risperidone in a randomized study in patients with schizophrenia. 113
Comparison of quetiapine, olanzapine and risperidone in schizophrenia. 113
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 112
Self-ordered pointing and visual conditional associative learning tasks in drug-free schizophrenia spectrum disorder patients. 111
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 111
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study 109
Depressive disorders and personality variables in HIV positive and negative intravenous drug-users 108
Season of birth and cerebral ventricular enlargement in schizophrenia 108
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 108
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 107
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 107
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 107
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 107
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 106
Comparison of Quetiapine, Olanzapine, and Risperidone in Patients With Schizophrenia: Interim Results of a Randomised, Rater-blinded Study. 106
The role of the cytochine network in schizophrenia: an overview. 106
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 105
Patterns of Brain Structural Changes in First-Contact, Antipsychotic Drug-Naive Patients with Schizophrenia. 104
Early life events and affective disorder revisited. 103
Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. 103
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 103
A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment. 102
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 102
Interim results of a randomised, rater-blinded study comparing quetiapine, olanzapine and risperidone in patients with schizophrenia. 102
Deranged anterior pituitary responsiveness to hypothalamic hormones in depressed patients 101
Variables associated with the hospitalization of psychiatric emergencies evaluated in the community. 100
Variables Associated With General Practitioners' Knowledge About and Diagnostic Skills for Schizophrenia 100
H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients. 100
Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial. 99
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 99
Structural brain abnormalities in bipolar disorder: what meta-analyses tell us 98
Cognitive remediation in schizophrenia: a controlled study 98
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 98
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review 97
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 97
Neuromorphological correlates of mood disorders: focus on cerebral ventricular enlargement. 97
Are SSRI antidepressants a clinically homogeneous class of compounds? 96
Immediate and 8-Month Impact of a Medical Educational Course for General Practitioners on Knowledge About Schizophrenia and Its Treatment: Results of a 3-Phase Study From Brescia, Italy. 96
Cortical atrophy in schizophrenia: prevalence and associated features 96
Reducing the "revolving door" phenomenon. 95
CT scan abnormalities and outcome of chronic schizophrenia 95
Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample 95
Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis 95
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 95
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 95
Long-acting risperidone improves negative symptoms in stable psychotic patients. 94
Long-term remission in schizophrenia and related psychoses with long-acting risperidone: results obtained in an open-label study with an observation period of 18 months. 93
DIRECT TRANSITION TO LONG-ACTING RISPERIDONE--ANALYSIS OF LONG-TERM EFFICACY. 93
Cytokine profiles in drug-naive schizophrenic patients. 93
CLINICAL ASSESSMENT OF COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA THROUGH THE SCHIZOPHRENIA COGNITION RATING SCALE: A VALIDATION STUDY IN THE ITALIAN POPULATION 92
Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences and contributing factors. 92
Analysis of Copy Number Variations in Schizophrenia Italian Patients 91
La cognitività sociale nella schizofrenia: modelli interpretativi e strategie di intervento 91
EEG power spectrum profile and structural CNS characteristics in schizophrenia. 90
Improving the chance of recovery from the short- and long-term consequences of depression. 89
A multimodal imaging study of never-medicated adults with schizophrenia 89
Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone. 88
Developmental brain abnormalities in schizophrenia: contributions of genetic and perinatal factors. 88
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 88
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 88
Late-onset schizophrenia: epidemiology, clinical profile, prognosis, and treatment considerations 87
New Copy Number Variations in Schizophrenia Italian Patients 86
Incidence of diabetes in a general practice population: a database cohort study on the relationship with haloperidol, olanzapine, risperidone or quetiapine exposure. 86
Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naive patients with schizophrenia. 86
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 86
Risk of stroke with typical and atypical anti-psychotics: a retrospective cohort study including unexposed subjects. 85
Carlo Lorenzo Cazzullo (1915-2010): father of Italian psychiatry 85
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 85
Study of the genetic architecture behind mood disorders by whole exome sequencing on a large Italian pedigree 84
Additional Evidence for White Matter Damage in Never-Medicated Adults with Schizophrenia and Schizophreniform Disorder 83
Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies. 82
Mitochondrial DNA haplogroups and age at onset of schizophrenia 82
Brain morphology in schizophrenia: a 2-to-5 year CT scan follow-up study 81
Timing of stroke in elderly people exposed to typical and atypical antipsychotics: a replication cohort study after the paper of Kleijer, et al. 81
Risk factors in schizophrenia. 80
Totale 11.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.807
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.853 0 145 145 453 249 482 456 460 322 551 335 255
2020/20212.782 69 326 69 293 120 311 140 314 373 295 368 104
2021/20221.441 113 267 26 66 32 65 69 90 82 166 133 332
2022/20231.603 219 24 17 165 130 433 1 185 281 17 57 74
2023/20241.466 95 37 115 109 73 376 61 51 277 28 19 225
2024/202576 39 37 0 0 0 0 0 0 0 0 0 0
Totale 16.686